The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection
- 1 June 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of Clinical Virology
- Vol. 36 (2) , 146-151
- https://doi.org/10.1016/j.jcv.2006.01.015
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Valacyclovir for Cytomegalovirus Prophylaxis Reduces the Risk of Acute Renal Allograft RejectionTransplantation, 2005
- Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patientsJournal of Clinical Virology, 2004
- Cytomegalovirus Prophylaxis and Graft Outcome in Solid Organ Transplantation: A Collaborative Transplant Study ReportAmerican Journal of Transplantation, 2004
- Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2004
- Cytomegalovirus and solid organ transplantation: an updateCurrent Opinion in Organ Transplantation, 2003
- Definitions of Cytomegalovirus Infection and Disease in Transplant RecipientsClinical Infectious Diseases, 2002
- Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analysesTransplant International, 2000
- Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infectionClinical and Experimental Immunology, 2000
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999